I am currently a Research Fellow at The Lundquist Institute (TLI). My work focuses on defining how chronic inflammatory signals reshape the tumor microenvironment and drive therapeutic resistance in glioblastoma and clarifying the functional consequences of gene mutations in neuroblastoma. My research integrates molecular biology, CRISPR-based genome editing, RNA sequencing, proteomic profiling, and functional assays to identify pathway-level vulnerabilities that may be exploited for therapeutic development. I design and lead independent projects, mentor junior researchers, and collaborate with multidisciplinary teams to advance translational cancer research across multiple programs.